148 related articles for article (PubMed ID: 17447055)
1. Identification of human hepatocellular carcinoma-related proteins by proteomic approaches.
Yang MH; Tyan YC; Jong SB; Huang YF; Liao PC; Wang MC
Anal Bioanal Chem; 2007 Jun; 388(3):637-43. PubMed ID: 17447055
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of proteomic components of sera from patients with hepatocellular carcinomas by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time of flying mass spectrometry].
Wang Z; Ruan YB; Guan Y
Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):333-6. PubMed ID: 14514378
[TBL] [Abstract][Full Text] [Related]
3. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
4. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS.
He X; Wang Y; Zhang W; Li H; Luo R; Zhou Y; Liao CL; Huang H; Lv X; Xie Z; He M
Neoplasma; 2014; 61(1):17-26. PubMed ID: 24195504
[TBL] [Abstract][Full Text] [Related]
5. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
Zhu J; Warner E; Parikh ND; Lubman DM
Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
[TBL] [Abstract][Full Text] [Related]
6. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
7. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
[TBL] [Abstract][Full Text] [Related]
8. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
9. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma.
Steel LF; Shumpert D; Trotter M; Seeholzer SH; Evans AA; London WT; Dwek R; Block TM
Proteomics; 2003 May; 3(5):601-9. PubMed ID: 12748940
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
11. Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Int J Mol Sci; 2010 Mar; 11(4):1423-33. PubMed ID: 20480028
[TBL] [Abstract][Full Text] [Related]
12. Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.
Megger DA; Bracht T; Kohl M; Ahrens M; Naboulsi W; Weber F; Hoffmann AC; Stephan C; Kuhlmann K; Eisenacher M; Schlaak JF; Baba HA; Meyer HE; Sitek B
Mol Cell Proteomics; 2013 Jul; 12(7):2006-20. PubMed ID: 23462207
[TBL] [Abstract][Full Text] [Related]
13. Quantification of glycocholic acid in human serum by stable isotope dilution ultra performance liquid chromatography electrospray ionization tandem mass spectrometry.
Guo C; Xie C; Ding P; Qin G; Mo W; Cao X; Zheng S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():315-319. PubMed ID: 29202363
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma.
Kim KH; Kim JY; Yoo JS
Expert Rev Proteomics; 2019 Jul; 16(7):553-568. PubMed ID: 31145639
[No Abstract] [Full Text] [Related]
15. Protein profiling of human plasma samples by two-dimensional electrophoresis.
Cho SY; Lee EY; Kim HY; Kang MJ; Lee HJ; Kim H; Paik YK
Methods Mol Biol; 2008; 428():57-75. PubMed ID: 18287768
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment.
Kawakami T; Hoshida Y; Kanai F; Tanaka Y; Tateishi K; Ikenoue T; Obi S; Sato S; Teratani T; Shiina S; Kawabe T; Suzuki T; Hatano N; Taniguchi H; Omata M
Proteomics; 2005 Nov; 5(16):4287-95. PubMed ID: 16254924
[TBL] [Abstract][Full Text] [Related]
17. LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.
Tsai TH; Wang M; Di Poto C; Hu Y; Zhou S; Zhao Y; Varghese RS; Luo Y; Tadesse MG; Ziada DH; Desai CS; Shetty K; Mechref Y; Ressom HW
J Proteome Res; 2014 Nov; 13(11):4859-68. PubMed ID: 25077556
[TBL] [Abstract][Full Text] [Related]
18. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.
Nagai K; Uranbileg B; Chen Z; Fujioka A; Yamazaki T; Matsumoto Y; Tsukamoto H; Ikeda H; Yatomi Y; Chiba H; Hui SP; Nakazawa T; Saito R; Koshiba S; Aoki J; Saigusa D; Tomioka Y
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1(Suppl 1):e8551. PubMed ID: 31412144
[TBL] [Abstract][Full Text] [Related]
20. Discovery of small extracellular vesicle proteins from human serum for liver cirrhosis and liver cancer.
Uzzaman A; Zhang X; Qiao Z; Zhan H; Sohail A; Wahid A; Shang Z; Guan X; Cao CX; Xiao H
Biochimie; 2020 Oct; 177():132-141. PubMed ID: 32835735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
